Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Apr-Jun;23(2-3):121-35.
doi: 10.1385/MN:23:2-3:121.

Vascular growth factors in cerebral ischemia

Affiliations
Review

Vascular growth factors in cerebral ischemia

S D Croll et al. Mol Neurobiol. 2001 Apr-Jun.

Abstract

During the past decade, there has been a surge of interest in growth factors (GFs) that act selectively on vascular endothelium and perivascular cells. Studies employing mutant mice or the administration of recombinant proteins have suggested that these factors not only mediate the proliferation of endothelial cells, but also regulate vascular differentiation, regression, and permeability. During and after cerebral ischemia, brain vasculature becomes leaky and unstable, and the normally impermeable blood-brain barrier breaks down. Several days after the ischemic insult, endothelial cells begin to proliferate, and angiogenesis occurs. Expression studies have shown that key vascular GFs are regulated, during these processes, in a complex and coordinated manner. The distinct pattern of regulation exhibited by each vascular GF suggests a unique role for each factor during the initial vascular destabilization and subsequent angiogenesis that occurs after cerebral ischemia. Data from studies in other biological systems support these suggested roles. Thus, manipulation of vascular GFs may prove to be an effective means of stabilizing or enriching brain vasculature after ischemia, and ameliorating the detrimental effects of blood-brain barrier breakdown and vessel regression after stroke.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1986 Nov;46(11):5629-32 - PubMed
    1. Arch Ophthalmol. 1995 Dec;113(12 ):1538-44 - PubMed
    1. J Clin Endocrinol Metab. 1998 Nov;83(11):3908-12 - PubMed
    1. Cell. 1998 Mar 20;92(6):735-45 - PubMed
    1. Cardiovasc Res. 2000 Aug;47(2):384-93 - PubMed

MeSH terms

Substances

LinkOut - more resources